Herman Waldemar Adam, Krzoska Anna, Pawliczak Elzbieta, Roszak Magdalena, Łacka Katarzyna
Pol Merkur Lekarski. 2014 Jan;36(211):16-21.
The prevalence of late-onset hipogonadism (LOH) in men is not accurately determined and may be overestimated. Androgen deficiency is causally linked to insulin resistance, regardless of age. Clinical signs of androgen deficiency are not uniquely specific for LOH. The aim of this study was to assess the correlations between androgen serum levels and clinical symptoms of andropenia depending on the age. We evaluated the relationships between the frequency of LOH and metabolic syndrome (MS) and compared different methods of androgen assessment in the context of their clinical relevance.
In 153 randomly selected men aged 40 to 70 years adrenal (DHEA and DHEAS) and gonadal (total-TT and free testosterone-FT) androgens were evaluated and compared with free (c-FT) and bioavailable testosterone (c-BAT) calculated with a mathematical algorithm. European Male Aging Study criteria for the diagnosis of LOH were used.
TT concentration (r = -0.074, p = 0.363) and FT (r = -0.054, p = 0.505) did not correlate with age, in contrast to the c-FT (r = -0.280, p = 0.0005 ), c-BAT (r = -0.297, p = 0.0002) and both adrenal androgens: DHEA (r = -0.318, p = 0.00001) and DHEAS (r = -0.506, p < 0.00001). The clinical signs suggesting andropenia were found in 31.4% of participants and androgen deficiency in 28.8% of men. The incidence of these signs increased significantly with the age of respondents. In contrast, the criteria of LOH in the entire group were fulfilled by only 6.5% of men. Men diagnosed with MS showed significantly lower TT plasma levels: 5.05 (3.70-6.45) vs. 6.30 (5.40-8.30), p < 0.0001--contrary to the FT, c-FT, c-BAT as well as DHEA/DHEAS serum levels, regardless of age. Men meeting the full criteria for LOH (clinical symptoms and laboratory-confirmed hipoandrogenemia) revealed more than a five-fold higher risk of metabolic syndrome in relation to others (OR = 5.533, 95% CI: 1.134-27.+ 01). Total, free, calculated-free and calculated-bioavailable testosterone serum concentrations were strongly correlated with each other. Similarly, the plasma concentrations of both adrenal androgens were mutually positively correlated (r = 0.417, p < 0.0001), but any correlation between the gonadal androgens and DHEA/DHEAS were revealed.
The prevalence of isolated hipoandrogenemia and clinical symptoms suggestive andropenia is clearly greater than the actual frequency of LOH. Fulfilling the criteria for LOH significantly increases the risk of MS.
男性迟发性性腺功能减退(LOH)的患病率尚未得到准确测定,可能被高估。雄激素缺乏与胰岛素抵抗存在因果关系,与年龄无关。雄激素缺乏的临床体征并非LOH所特有。本研究的目的是评估雄激素血清水平与不同年龄男性性腺功能减退临床症状之间的相关性。我们评估了LOH频率与代谢综合征(MS)之间的关系,并在临床相关性背景下比较了不同的雄激素评估方法。
在153名年龄在40至70岁之间随机选取的男性中,评估肾上腺(脱氢表雄酮和硫酸脱氢表雄酮)和性腺(总睾酮-TT和游离睾酮-FT)雄激素,并与通过数学算法计算出的游离(c-FT)和生物可利用睾酮(c-BAT)进行比较。采用欧洲男性衰老研究中LOH的诊断标准。
与c-FT(r = -0.280,p = 0.0005)、c-BAT(r = -0.297,p = 0.0002)以及两种肾上腺雄激素:脱氢表雄酮(r = -0.318,p = 0.00001)和硫酸脱氢表雄酮(r = -0.506,p < 0.00001)相反,TT浓度(r = -0.074,p = 0.363)和FT(r = -0.054,p = 0.505)与年龄无关。31.4%的参与者出现性腺功能减退的临床体征,28.8%的男性存在雄激素缺乏。这些体征的发生率随受访者年龄显著增加。相比之下,整个组中只有6.5%的男性符合LOH标准。被诊断为MS的男性血浆TT水平显著更低:5.05(3.70 - 6.45)对比6.30(5.40 - 8.30),p < 0.0001——与FT、c-FT、c-BAT以及脱氢表雄酮/硫酸脱氢表雄酮血清水平相反,与年龄无关。符合LOH全部标准(临床症状和实验室确诊的低雄激素血症)的男性与其他人相比,代谢综合征风险高出五倍多(OR = 5.533,95% CI:1.134 - 27. + 01)。总睾酮、游离睾酮、计算出的游离睾酮和计算出的生物可利用睾酮血清浓度彼此高度相关。同样,两种肾上腺雄激素的血浆浓度相互呈正相关(r = 0.417,p < 0.0001),但未发现性腺雄激素与脱氢表雄酮/硫酸脱氢表雄酮之间存在任何相关性。
孤立性低雄激素血症和提示性腺功能减退的临床症状的患病率明显高于LOH的实际发生率。符合LOH标准会显著增加MS的风险。